Clinical Trial Update: The Effect of Norgestimate/Ethinyl Estradiol on Bone Density in Pediatric Subjects With Anorexia Nervosa [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating the effect of ethinyl estradiol/norgestimate on bone density in pediatric patients with anorexia nervosa.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Osteoporosis

Drugs mentioned

• Ethinyl estradiol/norgestimate (ethinyl estradiol + norgestimate)

Snippet

Sponsor: McNeil Consumer & Specialty Pharmaceuticals, a Division of McNeil-PPC, Inc. | Conditions: Osteoporosis | Phase 2 | Status: COMPLETED